Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong
· Delayed Price · Currency is HKD 104.30
+2.50 (2.46%)
Last updated: Mar 10, 2026, 1:57 PM HKT
HKG:2659 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 |
|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cash & Equivalents | 453.39 | 524.16 | 321.67 |
| Short-Term Investments | 1.01 | 1.18 | 2.46 |
| Cash & Short-Term Investments | 454.4 | 525.33 | 324.13 |
| Cash Growth | - | 62.08% | - |
| Accounts Receivable | 0.12 | 0.14 | 2 |
| Other Receivables | - | - | 0.04 |
| Receivables | 0.12 | 0.14 | 2.04 |
| Inventory | 5.36 | 4.72 | 8.07 |
| Prepaid Expenses | 0.54 | 0.83 | 1.05 |
| Other Current Assets | 139.81 | 134.56 | 30.85 |
| Total Current Assets | 600.24 | 665.58 | 366.15 |
| Property, Plant & Equipment | 735.85 | 677.13 | 585.42 |
| Long-Term Investments | 7.71 | 7.83 | 8.44 |
| Other Intangible Assets | 11.98 | 12.32 | 12.57 |
| Other Long-Term Assets | 32.91 | 0.41 | 1.31 |
| Total Assets | 1,389 | 1,363 | 973.88 |
| Accounts Payable | - | 0.34 | - |
| Accrued Expenses | 14.59 | 20.44 | 12.14 |
| Short-Term Debt | - | 29.83 | 20.02 |
| Current Portion of Long-Term Debt | 73.22 | 39.74 | 45.09 |
| Current Portion of Leases | 1.71 | 1.56 | 0.92 |
| Current Income Taxes Payable | 1.04 | 1.16 | 0.98 |
| Current Unearned Revenue | 0.54 | 58.37 | 18.36 |
| Other Current Liabilities | 196.78 | 44.79 | 49.31 |
| Total Current Liabilities | 287.87 | 196.23 | 146.82 |
| Long-Term Debt | 170.2 | 132.29 | 44.98 |
| Long-Term Leases | 1.1 | 1.84 | 0.1 |
| Long-Term Unearned Revenue | 39.93 | 37.03 | 32.83 |
| Long-Term Deferred Tax Liabilities | - | - | 0.02 |
| Total Liabilities | 499.1 | 367.39 | 224.75 |
| Common Stock | 57.61 | 57.26 | 52.05 |
| Additional Paid-In Capital | 1,483 | 1,453 | 1,000 |
| Retained Earnings | -850.76 | -667.66 | -303.23 |
| Comprehensive Income & Other | 199.96 | 153.15 | - |
| Shareholders' Equity | 889.59 | 995.88 | 749.13 |
| Total Liabilities & Equity | 1,389 | 1,363 | 973.88 |
| Total Debt | 246.23 | 205.26 | 111.12 |
| Net Cash (Debt) | 208.18 | 320.08 | 213.01 |
| Net Cash Growth | - | 50.26% | - |
| Net Cash Per Share | 3.70 | 5.98 | 4.21 |
| Filing Date Shares Outstanding | 57.61 | 286.3 | 50.59 |
| Total Common Shares Outstanding | 57.61 | 286.3 | 50.59 |
| Working Capital | 312.37 | 469.35 | 219.32 |
| Book Value Per Share | 15.44 | 3.48 | 14.81 |
| Tangible Book Value | 877.61 | 983.56 | 736.56 |
| Tangible Book Value Per Share | 15.23 | 3.44 | 14.56 |
| Buildings | 199.13 | 199.13 | 199.13 |
| Machinery | 193.41 | 176.61 | 164.47 |
| Construction In Progress | 359.63 | 302.12 | 199.59 |
Source: S&P Capital IQ. Standard template. Financial Sources.